2,3-DIPHOSPHO-D-GLYCERIC ACID PENTASODIUM SALT
2,3-DIPHOSPHO-D-GLYCERIC ACID PENTASODIUM SALT structure
|
Common Name | 2,3-DIPHOSPHO-D-GLYCERIC ACID PENTASODIUM SALT | ||
|---|---|---|---|---|
| CAS Number | 102783-53-9 | Molecular Weight | 375.946 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C3H3Na5O10P2 | Melting Point | N/A | |
| MSDS | Chinese USA | Flash Point | N/A | |
Use of 2,3-DIPHOSPHO-D-GLYCERIC ACID PENTASODIUM SALT2,3-Diphospho-D-glyceric acid pentasodium salt is a highly anionic polyphosphorus compound. 2,3-Diphospho-D-glyceric acid is present in the concave center of red blood cells, it binds hemoglobin to reduce its oxygen affinity. 2,3-Diphospho-D-glyceric acid is an endogenous, selective inhibitor of vascular calcification (VC) and significantly delays the formation of crystalline calpain particles (CPP). 2,3-Diphospho-D-glyceric acid also inhibits calcification in mouse vascular smooth muscle cell line (MOVAS) without cytotoxic effects[1]. |
| Name | 2,3-Diphospho-D-glyceric acid pentasodium salt |
|---|---|
| Synonym | More Synonyms |
| Description | 2,3-Diphospho-D-glyceric acid pentasodium salt is a highly anionic polyphosphorus compound. 2,3-Diphospho-D-glyceric acid is present in the concave center of red blood cells, it binds hemoglobin to reduce its oxygen affinity. 2,3-Diphospho-D-glyceric acid is an endogenous, selective inhibitor of vascular calcification (VC) and significantly delays the formation of crystalline calpain particles (CPP). 2,3-Diphospho-D-glyceric acid also inhibits calcification in mouse vascular smooth muscle cell line (MOVAS) without cytotoxic effects[1]. |
|---|---|
| Related Catalog | |
| References |
| Molecular Formula | C3H3Na5O10P2 |
|---|---|
| Molecular Weight | 375.946 |
| Exact Mass | 375.868988 |
| PSA | 204.59000 |
| Personal Protective Equipment | Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter |
|---|---|
| RIDADR | NONH for all modes of transport |
| WGK Germany | 3 |
|
Polyphosphates and pyrophosphates of hexopyranoses as allosteric effectors of human hemoglobin: synthesis, molecular recognition, and effect on oxygen release.
ChemMedChem 6(1) , 153-68, (2011) Polyphosphorylated and perphosphorylated hexopyranose monosaccharides and disaccharides were synthesized from parent or partially protected carbohydrates as potential allosteric effectors of hemoglobi... |
|
|
Development of a bifunctional filter for prion protein and leukoreduction of red blood cell components.
Transfusion 55(2) , 330-6, (2015) Leukofiltration of blood components is currently implemented worldwide as a precautionary measure against white blood cell-associated adverse effects and the potential transmission of variant Creutzfe... |
|
|
Red blood cell in vitro quality and function is maintained after S-303 pathogen inactivation treatment.
Transfusion 54(7) , 1798-807, (2014) Over the past decade there has been a growth in the development of pathogen reduction technologies to protect the blood supply from emerging pathogens. This development has proven to be difficult for ... |
| Pentasodium (2R)-2,3-bis(phosphonatooxy)propanoate |
| Propanoic acid, 2,3-bis(phosphonooxy)-, sodium salt, (2R)- (1:5) |
| 2,3-diphospho-d-glyceric acid pentasodium salt |